Established Pharmaceutical Manufacturer with Patented Technology and Global Reach
Financial Details
- Asking Price:
- $40,000,000
- Annual Revenue:
- $25,000,000
- Cash Flow / SDE:
- $3,000,000
- Profit Metric:
- EBITDA
- Valuation Multiple:
- 13.3x
- Location:
- IN
- Source:
- Date:
- September 15, 2025
Key Highlights
Description
This is a well-established, 40-year-old pharmaceutical manufacturing business with a strong reputation and a diverse product portfolio. The company specializes in a wide range of offerings, from antibiotics and vitamins to anti-coagulants and ophthalmic products, serving major global clients including Pfizer, Abbott, Cipla, and Glenmark. It holds certifications such as ISO9001 and EU Standards, and is GMP audited by regulatory bodies in India and overseas. A key differentiator is its proprietary patented technology for a recombinant protein targeting novel therapies with no side effects, alongside ongoing research in stem cell rejuvenation and biotechnology for targeted human therapeutic proteins. The business boasts a growth rate of over 20% annually, supported by a dedicated team of 100 professionals including chemists, pharmacists, biotechnologists, and R&D experts. The market is split 65% India and 35% international (Rest of World/Europe). Financials indicate $25M in revenue and $3M in EBITDA.
Industry Information
- Industry Description:
- Pharmaceutical Manufacturing
- Classification:
- Manufacturing
Operational Snapshot
- Year Established:
- 1985
- Employees:
- 100
Real Estate & Lease
- Status:
- Not Specified
Listing Details
- Listing ID:
- af5d7456-e51a-407c-9752-0d68fec6c2b3
- Deal Status:
- For Sale
- Date Posted:
- December 15, 2022
- Last Updated:
- September 15, 2025
- Currency:
- USD